Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 69.39M | 70.91M | 72.11M | 72.11M | 69.81M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 69.39M | 70.91M | 72.11M | 72.11M | 69.81M |
Cost of Revenue | 41.03M | 43.17M | 42.16M | 42.16M | 42.00M |
Gross Profit | 28.36M | 27.75M | 29.95M | 29.95M | 27.81M |
SG&A Expenses | 23.61M | 40.26M | 24.99M | 24.99M | 25.19M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 93.00K | -760.00K | -1.16M | -1.16M | 2.58M |
Total Operating Expenses | 64.73M | 82.67M | 65.99M | 65.99M | 69.77M |
Operating Income | 4.66M | -11.75M | 6.12M | 6.12M | 41.00K |
Income Before Tax | 54.26M | -34.53M | -36.03M | -36.03M | -67.09M |
Income Tax Expenses | 43.00K | 594.00K | -1.57M | -1.57M | -13.84M |
Earnings from Continuing Operations | 54.21M | -35.13M | -34.46M | -34.46M | -53.24M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 54.21M | -35.13M | -34.46M | -34.46M | -53.24M |
EBIT | 4.66M | -11.75M | 6.12M | 6.12M | 41.00K |
EBITDA | 8.56M | -10.83M | 9.93M | 9.93M | 3.87M |
EPS Basic | 0.12 | -0.07 | -0.07 | -0.07 | -0.11 |
Normalized Basic EPS | 0.08 | -0.04 | -0.05 | -0.05 | -0.09 |
EPS Diluted | 0.12 | -0.07 | -0.07 | -0.07 | -0.11 |
Normalized Diluted EPS | 0.08 | -0.04 | -0.05 | -0.05 | -0.09 |
Average Basic Shares Outstanding | 451.78M | 501.79M | 492.26M | 492.26M | 484.04M |
Average Diluted Shares Outstanding | 451.78M | 501.79M | 492.26M | 492.26M | 484.04M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |